Opportunity Information: Apply for 72067425RFA00001
The USAID South Africa mission in Pretoria is soliciting applications for a discretionary health cooperative agreement titled "HIV Prevention Among Adolescent Girls and Young Women and Other Vulnerable Youth Populations - DREAMS North" (Funding Opportunity Number 72067425RFA00001). The central purpose of the activity is to substantially reduce new HIV infections among adolescent girls and young women (AGYW) ages 10 to 24 in selected high-burden areas of South Africa. The program is framed around the idea that HIV incidence can be driven down by expanding AGYW access to a comprehensive, age-appropriate package of prevention services that are grounded in evidence and that directly tackle the main drivers of risk, including biological factors, behavioral risks, and socio-economic vulnerabilities.
The proposed activity focuses on delivering an integrated prevention approach rather than a single intervention. It emphasizes improving availability and uptake of interventions designed for different age bands within 10-24, recognizing that younger adolescents and older young women often face different risks and barriers to care. Within the prevention package, the opportunity explicitly prioritizes reliable access to contraception, sexually transmitted infection (STI) treatment, and post-exposure prophylaxis (PEP), signaling a strong expectation that the implementer will ensure these commodities and services are accessible, appropriately targeted, and delivered in a way that is practical for young people to use. The overall intent aligns with DREAMS-style programming, which typically combines clinical services with community and structural supports to reduce vulnerability and make prevention options realistic and sustainable.
Geographically, the activity is anticipated to operate in three provinces described as areas with the highest HIV incidence and prevalence. In Mpumalanga, the anticipated districts are Gert Sibanda, Nkangala, and Ehlanzeni. In Gauteng, the areas include the City of Johannesburg and Sedibeng. In Limpopo, the anticipated districts are Mopani and Capricorn. Applicants should read this as a clear sign that implementation is expected to be concentrated in these specific localities, with programming designed around the needs, service landscape, and epidemic dynamics of these districts.
This funding opportunity is structured as a cooperative agreement, which generally means USAID expects substantial involvement during implementation (for example, ongoing coordination on work planning, monitoring, and adaptive management), rather than a hands-off grant model. The total ceiling amount listed is up to $58,000,000, and USAID anticipates making one award, suggesting a single prime partner will be responsible for leading and coordinating implementation across the targeted provinces and districts. The opportunity is listed under CFDA 98.001 and categorized under health.
Eligibility is restricted to local South African entities, meaning only organizations that meet the NOFO's definition of a local entity are allowed to apply. Any interested applicant would need to rely on the full Notice of Funding Opportunity for the precise eligibility tests and documentation requirements. Key dates included in the posting indicate the opportunity was created on December 13, 2024, with an original closing date of February 11, 2025.Apply for 72067425RFA00001
- The South Africa USAID-Pretoria in the health sector is offering a public funding opportunity titled "HIV Prevention Among Adolescent Girls and Young Women and Other Vulnerable Youth Populations - DREAMS North" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on 2024-12-13.
- Applicants must submit their applications by 2025-02-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $58,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1) What is the name of this funding opportunity?
The opportunity is a discretionary health cooperative agreement titled "HIV Prevention Among Adolescent Girls and Young Women and Other Vulnerable Youth Populations - DREAMS North."
2) What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is 72067425RFA00001.
3) Which USAID office is issuing this opportunity?
This opportunity is being solicited by the USAID South Africa mission in Pretoria.
4) What is the main purpose of the activity?
The central purpose is to substantially reduce new HIV infections among adolescent girls and young women (AGYW) ages 10 to 24 in selected high-burden areas of South Africa.
5) Who is the primary target population?
The primary target population is adolescent girls and young women (AGYW) ages 10 to 24.
6) Does the opportunity include other groups besides AGYW?
Yes. The title references "other vulnerable youth populations," but the central purpose as described focuses on reducing new HIV infections among AGYW ages 10 to 24.
7) What overall approach does USAID expect for HIV prevention in this activity?
USAID describes an integrated, comprehensive prevention approach rather than a single intervention. The intent is to expand access to an evidence-grounded, age-appropriate package of prevention services that addresses key drivers of HIV risk, including biological factors, behavioral risks, and socio-economic vulnerabilities.
8) Is the program intended to be "DREAMS-style" programming?
Yes. The opportunity aligns with DREAMS-style programming, which typically combines clinical services with community and structural supports to reduce vulnerability and make prevention options realistic and sustainable.
9) Are there expectations to tailor programming by age group within 10 to 24?
Yes. The opportunity emphasizes improving availability and uptake of interventions designed for different age bands within 10 to 24, recognizing that younger adolescents and older young women can face different risks and barriers to care.
10) Which prevention commodities and services are explicitly prioritized?
Within the prevention package, the opportunity explicitly prioritizes reliable access to contraception, sexually transmitted infection (STI) treatment, and post-exposure prophylaxis (PEP).
11) What does USAID signal by prioritizing contraception, STI treatment, and PEP?
It signals a strong expectation that the implementer will ensure these commodities and services are accessible, appropriately targeted, and delivered in a way that is practical for young people to use.
12) Is this opportunity focused on one specific intervention?
No. The description emphasizes delivering an integrated prevention approach rather than a single intervention.
13) Where in South Africa is the activity expected to operate?
The activity is anticipated to operate in three provinces described as having the highest HIV incidence and prevalence: Mpumalanga, Gauteng, and Limpopo.
14) Which districts are anticipated in Mpumalanga?
In Mpumalanga, the anticipated districts are Gert Sibanda, Nkangala, and Ehlanzeni.
15) Which areas are anticipated in Gauteng?
In Gauteng, the anticipated areas include the City of Johannesburg and Sedibeng.
16) Which districts are anticipated in Limpopo?
In Limpopo, the anticipated districts are Mopani and Capricorn.
17) Should applicants assume implementation will be concentrated in these listed localities?
Yes. The opportunity states that applicants should read this as a clear sign that implementation is expected to be concentrated in these specific localities, with programming designed around the needs, service landscape, and epidemic dynamics of these districts.
18) What type of award is being offered?
This opportunity is structured as a cooperative agreement.
19) What does a cooperative agreement imply about USAID's role?
A cooperative agreement generally means USAID expects substantial involvement during implementation, such as ongoing coordination on work planning, monitoring, and adaptive management, rather than a hands-off grant model.
20) What is the total funding ceiling amount?
The total ceiling amount listed is up to $58,000,000.
21) How many awards does USAID anticipate making?
USAID anticipates making one award.
22) What does "one award" suggest about how implementation will be organized?
It suggests a single prime partner will be responsible for leading and coordinating implementation across the targeted provinces and districts.
23) What is the CFDA/Assistance Listing number and sector category?
The opportunity is listed under CFDA 98.001 and categorized under health.
24) Who is eligible to apply?
Eligibility is restricted to local South African entities, meaning only organizations that meet the Notice of Funding Opportunity (NOFO) definition of a local entity are allowed to apply.
25) Where can applicants find the exact eligibility requirements?
Applicants would need to rely on the full Notice of Funding Opportunity (NOFO) for the precise eligibility tests and documentation requirements.
26) When was the opportunity created?
The posting indicates the opportunity was created on December 13, 2024.
27) What was the original closing date?
The original closing date listed is February 11, 2025.
Browse more opportunities from the same category: Health
Next opportunity: NM FY25 IIJA/IRA Bureau of Land Management New Mexico Cultural and Paleontological Resource Management
Previous opportunity: F25AS00133 Rhinoceros and Tiger Conservation Fund - ASIA FY25
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for 72067425RFA00001
Applicants also applied for:
Applicants who have applied for this opportunity (72067425RFA00001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) Apply for RFA HL 25 011 Funding Number: RFA HL 25 011 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional) Apply for RFA DC 25 002 Funding Number: RFA DC 25 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) Apply for RFA HG 25 009 Funding Number: RFA HG 25 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Research Opportunities for New Investigators to Promote Workforce Development (R01 Clinical Trial Optional) Apply for RFA DC 25 004 Funding Number: RFA DC 25 004 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) Apply for PAR 25 032 Funding Number: PAR 25 032 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| New Partners Initiative Translational HIV Research for Innovative Vaccines Ecosystem (NPI THRIVE) Apply for 7200AA25RFA00001 Funding Number: 7200AA25RFA00001 Agency: Agency for International Development Category: Health Funding Amount: $98,500,000 |
| Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed) Apply for PAR 25 326 Funding Number: PAR 25 326 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed) Apply for PAR 25 315 Funding Number: PAR 25 315 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R21 Clinical Trial Not Allowed) Apply for PAR 25 316 Funding Number: PAR 25 316 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional) Apply for PAR 25 327 Funding Number: PAR 25 327 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) Apply for PAR 25 194 Funding Number: PAR 25 194 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) Apply for PAR 25 195 Funding Number: PAR 25 195 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Prevention Among Adolescent Girls and Young Women and Other Vulnerable Youth Populations - DREAMS South Apply for 72067425RFA00002 Funding Number: 72067425RFA00002 Agency: South Africa USAID-Pretoria Category: Health Funding Amount: $58,000,000 |
| Delta Health Systems Implementation Program Apply for HRSA 25 032 Funding Number: HRSA 25 032 Agency: Health Resources and Services Administration Category: Health Funding Amount: $400,000 |
| National Women’s Mental Health and Substance Use Technical Assistance Center Apply for SM 25 014 Funding Number: SM 25 014 Agency: Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $2,500,000 |
| REQUEST FOR INFORMATION (RFI) - USAID Catalyzing Access to FP Apply for RFI 720656 2024 FP Funding Number: RFI 720656 2024 FP Agency: Mozambique USAID-Maputo Category: Health Funding Amount: Case Dependent |
| Enhanced Surveillance and Control of Endemic and Emerging Arboviruses in Puerto Rico Apply for RFA CK 25 182 Funding Number: RFA CK 25 182 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $5,000,000 |
| Ryan White HIV/AIDS Program Part F Dental Reimbursement Program (DRP) Apply for HRSA 25 051 Funding Number: HRSA 25 051 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Ryan White HIV/AIDS Program Part C Capacity Development Program Apply for HRSA 25 049 Funding Number: HRSA 25 049 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Addressing Stigma to End the HIV Epidemic in the U.S. Apply for HRSA 25 060 Funding Number: HRSA 25 060 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "72067425RFA00001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
